Our Physicians
DR. PAUL DUIC  Paul
Duic, M.D., is a Neuro-Oncologist. He specializes
in the medical management of brain tumors and spine
tumors, including central nervous system (CNS) tumors,
gliomas, metastatic tumors, and CNS lymphoma.
Dr. Duic received his undergraduate degree, Bachelor of Sciences, in Biological Sciences, from Columbia University, New York, NY magna cum laude. He obtained his medical degree at NYU School of Medicine, New York, NY. Dr. Duic completed a Residency in Emergency Medicine at Johns Hopkins University. He also completed a Surgical Internship and three years of Neurological Surgery Residency at UC Davis Medical Center, Sacramento, CA. He subsequently completed a Fellowship in Neuro-Oncology at the Neuro-Oncology Branch of the National Cancer Institute, National Institutes of Health (NIH.) He returned to the Neuro-Oncology Branch of NIH before joining Neurological Surgery, P.C. Dr. Duic has also served as a Lieutenant Commander in the Medical Corps of the United States Naval Reserve. Dr. Duic published “Central Nervous System Tumors” in the Bethesda Handbook of Clinical Oncology. He has several manuscripts in preparation, including:“Selective Glioma Targeting by a Recombinant Adeno-Associated Virus Type 5 Vector,” and “Phase I Study of CC-8490, a Selective Estrogen Receptor Modulator, in Patients With Recurrent Malignant Gliomas and Progressive, Diffuse, Infi ltrating Gliomas.” He is an experienced co-investigator on multiple clinical trials at NIH involving many novel molecularly targeted agents. He has delivered neurosurgical grand rounds and spoken on several other occasions regarding these clinical trials, such as “The Development of Enzastaurin for Malignant Gliomas.”
RECENT PUBLICATIONS .................................... "Eltrombopag for the Treatment of Radiation-Induced Thrombocytopenia in a Patient with a Glioblastoma" "Trial of Talampanel, a Glutamate Receptor Inhibitor, for Adults With Recurrent Malignant Gliomas" "OmmayaCisternography with Delayed Radiotracer Activity Demonstrated in the Peritoneal Cavity" "A Phase I Trial of Enzastaurin in Patients with Recurrent Gliomas" "A Phase II Trial of Single Agent Bevacizumab Followed by BevacizumabPlusIrinotecan at Tumor Progression in Patients with Recurrent Glioblastoma." "Germinoma" "Spinal Ependymoma" "A Phase I Trial of Lenalidomide in Patients With Recurrent Primary Central Nervous System Tumors." "Central Nervous System Tumors"
Interview video with Paul Duic, M.D. |
|
• Medical
Management
of Brain Tumors More information on our neuro-oncology
Long Island Brain Tumor Center at Neurological Surgery, P.C., offers New Treatment for Recurrent Glioblastoma Using Electrical Fields, NovoTTF™ System Prevents Cancer Cells from Dividing .................................... .................................... Dr Paul Duic will be doing Grand Rounds at Brookhaven Hospital ....................................
Co-investigating clinical study ....................................
....................................
.................................... HYPERBARIC OXYGEN MAY HELP IN TREATING AGGRESSIVE BRAIN CANCER .................................... NEW TREATMENTS FOR BRAIN TUMORS LYMPHOMA AND OTHER CANCERS OF THE BRAIN Paul Duic, M.D., Neuro-Oncologist, has been appointed Clinical Assistant Professor of Neurology at SUNY Stony Brook University Hospital. | October 2009 A Harvest of Health and Hope NSPC's Neuro-Oncologist, Dr. Paul Duic
was a speaker at Celebrating the food and
wine of Long Island.
......................................
Dr. Duic is affiliated with the following hospitals
|
